Status:
COMPLETED
microRNA Profile in Early-stage Cervical Cancer
Lead Sponsor:
National Institute of Cancerología
Conditions:
Cervical Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Persistent infections with high-risk subtypes of the human papillomavirus (HPV) are recognized as the etiological factor for developing cervical cancer. The aim od this study was to identify a miRNA p...
Detailed Description
Cervical carcinoma (CC) is one of the most common cancers in women from countries with emerging economies; in Mexico, CC has the second highest incidence and mortality rate. Several studies have demon...
Eligibility Criteria
Inclusion
- Cervical cancer histopathological diagnosis
- Clinical stage IB1 or IIA1 CC
- Treated with radical hysterectomy (RH) with bilateral pelvic lymphadenectomy (BPL)
Exclusion
- Double primary tumors
- Treatment regimens other than standard treatment
- Poor quality formalin-fixed paraffin-embedded tissue blocks
Key Trial Info
Start Date :
September 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2013
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04087785
Start Date
September 1 2006
End Date
September 30 2013
Last Update
September 13 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.